Elli Kusmayanti
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Pasien laki-laki 14 Tahun dengan Hemoptysis ec TB Paru Hazma Wildani Hasibuan; Elli Kusmayanti
Jurnal Medika Nusantara Vol. 2 No. 3 (2024): Agustus : Jurnal Medika Nusantara
Publisher : Stikes Kesdam IV/Diponegoro Semarang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59680/medika.v2i3.1270

Abstract

Tuberculosis is a direct infectious disease caused by the TB germ. The clinical features of pulmonary tuberculosis in children vary and are often related to the age of onset of the disease. Pulmonary tuberculosis should be suspected in children who show symptoms and have a history of exposure to tuberculosis in the home environment. This case report was obtained from primary data through history taking, physical examination and supporting examination. The male patient aged 14 years and 7 months came with a complaint of bloody cough 8 days before admission. The patient was referred from PMI Hospital to the emergency room of Cut Meutia Hospital with complaints of coughing with blood since 8 days smrs. Cough was complained occasionally and accompanied by phlegm in the last 2 months. The patient complained of fever that had been felt since 3 weeks ago. History of complete TB treatment and a history of contact with TB patients. Physical examination found additional breath sounds of rhonki and wheezing in both lung fields and thorax X-rays with the impression of active pulmonary TB. The management given is 2RHZ + 4RH OAT therapy given for 6 months, 2 months intensive, 4 months follow-up and symptomatic therapy.
Kajian Teoritis Immune Trombositopenia pada Anak: Aspek Klinis, Prognosis, dan Pendekatan Terapi Debita Syahira; Elli Kusmayanti
Vitamin : Jurnal ilmu Kesehatan Umum Vol. 3 No. 4 (2025): October : Vitamin : Jurnal ilmu Kesehatan Umum
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/vitamin.v3i4.1737

Abstract

Immune Thrombocytopenic Purpura (ITP) is a bleeding disorder characterized by a low platelet count (<100,000/µL) caused by decreased platelet production or opsonization by antibodies, leading to platelet destruction by the reticuloendothelial system. ITP is one of the most common etiologies of bleeding disorders, especially in children. The prevalence of ITP in children is estimated to be around 1.9 to 6.4 cases per 100,000 children annually, while in adults, the prevalence is lower, at about 3.3 cases per 100,000 people per year. In the United States, the incidence of ITP is reported to be around 1.6 per 10,000 people annually. Clinical manifestations of ITP include petechiae, purpura, and/or ecchymosis, which are usually found on the upper and lower extremities. Mucocutaneous bleeding symptoms such as epistaxis and gum bleeding are also common in patients. These symptoms can vary depending on the severity of thrombocytopenia and individual responses to the condition. Diagnosis of ITP is made through a thorough medical history, physical examination, and rapid supportive tests to confirm the diagnosis and differentiate ITP from other conditions with similar symptoms. Proper and timely management is crucial to prevent further complications, including more severe bleeding or organ damage. With effective management, the quality of life of patients can be improved, and the risks associated with ITP can be minimized. Therefore, early detection and optimal management are key in addressing ITP, particularly in children who are more vulnerable to this bleeding disorder.